Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EBOS Group Limited ( (AU:EBO) ) has issued an update.
EBOS Group Limited has set the strike price for shares to be issued under its dividend reinvestment plan at NZ$22.09 per share for the dividend payable on 27 March 2026. The price will determine how many new shares DRP participants receive in lieu of cash, reflecting a 2.0% discount to the volume weighted average price of EBOS shares traded on the NZX over the five trading days from 9 to 13 March 2026.
This move confirms the terms for equity-based participation in the upcoming dividend and slightly incentivises shareholders to reinvest their payouts, modestly supporting capital retention within the company. The discounted DRP pricing may enhance liquidity in EBOS shares and signals continued use of reinvestment mechanisms as part of the company’s capital management strategy.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$30.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited is a New Zealand and Australia-based company operating in the healthcare and pharmaceutical distribution sector. It provides a range of products and services across the healthcare supply chain, supporting medical, pharmacy and related markets in both countries.
Average Trading Volume: 125,434
Technical Sentiment Signal: Sell
Current Market Cap: A$3.84B
See more insights into EBO stock on TipRanks’ Stock Analysis page.